Poster Abstract Session:
50. Antimicrobial Stewardship: Interventions Leveraging the Electronic Health Record
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID

Use of Electronic Best Practice Alert (BPA) to Reduce Inappropriate Testing for Clostridium difficile infection (CDI) at a Tertiary Care Center
John P. Mills, MD; Robert Chang, MD, FACP, SHFM; Krishna Rao, MD, MS; Chris Zimmerman, PharmD; Hee-Won Yoon, MPH; Carolyn Dombecki, MPH, CIC; Laraine L. Washer, MD
Impact of a Best Practice Alert Linking Clostridium difficile Infection Test Results to a Severity-based Treatment Order Set
Holly Reed, PharmD; Trevor Van Schooneveld, MD, FACP; Craig Reha, PharmD; Scott Bergman, PharmD, FIDSA, FCCP, BCPS
Best Practice Advisory Decreases Inpatient Urine Culture Orders
Alisha Skinner, MD; Heather Young, MD; Kati Shihadeh, PharmD; Bryan Knepper, MPH, MS, CIC; Timothy C. Jenkins, MD
  • BPA UCx poster.pdf (947.0 kB)
  • 181
    Evaluation of a Pilot Initiative for Tracking and Monitoring Indications Associated with Antibiotic Orders
    Jamie John, PharmD; Nicole Harrington, PharmD, BCPS; Julianne Gardner, PharmD; Jillian Dougherty, PharmD, BCPS; Donna Walsh, PharmD; Erin Dzuriak, PharmD; Marci Drees, MD, MS; Stephen Eppes, MD; Sharath Kharidi, MD; Linda Cheung, PharmD Candidate
    Successes of a system-directed and multi-faceted inpatient antimicrobial stewardship program in a large, integrated delivery organization
    Peter Colley, PharmD, BCPS-AAHIVQ; Rema Thyagarajan, PharmD, BCPS; Hoa Nguyen, MD, MS, PhD; Andrew Masica, MD, MSCI; Donald Storey, MD
  • IDWeek2018 System ASP.pdf (248.4 kB)
  • 184
    Implementation and Evaluation of an Electronic Antimicrobial Prior Authorization Approval Process at a Large Academic Medical Center
    Jimish Mehta, PharmD, MSCE; Jonathan Olson, BS; W Joseph Ketcherside, MD; Lauren Hunt, PharmD, BCPS; Brandon Palermo, MD, MPH; Keith Hamilton, MD
    Title: Effective Antimicrobial StewaRdship StrategIES (ARIES): cluster-randomized trial of a clinical decision support system to supplement antibiotic prospective review and feedback
    Shi Thong Heng, BSc (Pharm); Joshua Wong, Master of Science (Statistics); Barnaby Young, MSc, MB BChir, MRCP, DLSHTM; Li Min Ling, MBBS; Brenda Ang, MBBS, M Med, MPH, FAMS, FSHEA; Tau Hong Lee, MBBS; Angela Chow, MBBS, MMed, MS, PhD; Min Yi Yap, Bsc Pharm; Hui Lin Tay, Msc Clinical Pharmacy; Sock Hoon Tan, Bachelor of Science (Pharmacy); Christine Teng, MS; David Lye, FRACP, FAMS, FRCP; Tat Ming Ng, Doctor of Pharmacy (PharmD)
  • ID week 2018 ARIES.pdf (597.8 kB)
  • 187
    Comparison of Active versus Passive Strategies in Improving Compliance to Antimicrobial Stewardship Interventions
    Sarah Si Lin Tang, BSc (Pharm) (Hons); Yvonne Peijun Zhou, BSc (Pharm) (Hons); Liwen Loo, BSc (Pharm) (Hons); Andrea L. Kwa, PharmD; Piotr Chlebicki, MBBS
  • CDSSAA poster.pdf (590.1 kB)
  • 188
    A Novel inpatient Antibiotic Stewardship Assistance Program (ASAP) using Real-Time Electronic Health Record Data, Prediction Modeling and Epidemiologic Data to Provide Personalized Empiric Antibiotic Recommendations
    Nirav Shah, MD; Mary Ellen Acree, MD; Clayton Patros, PharmD, BCPS; Mira Suseno, PharmD; Jennifer Grant, MD; Gary Fleming, BE; Bryce Hadsell, BS; Jeffery Semel, MD, FIDSA, FSHEA; Courtney Hebert, MD, MS; Kamaljit Singh, MD; Lance Peterson, MD
    Evaluating the impact of mandatory indications on antibiotic utilization: a retrospective study
    April Jane Chan, BScPharm ACPR PharmD BCPS; Mark Downing, MD; Bradley Langford, BScPhm ACPR PharmD BCPS
    Promise and pitfalls: analyzing the accuracy and perceptions of documenting antibiotic indication during order entry
    James Beardsley, PharmD; Mark Vestal, PharmD; Norbert Rosario, PharmD; Kalyn Meosky, PharmD; James Johnson, PharmD; John Williamson, PharmD; Vera Luther, MD; Christopher Ohl, MD, FIDSA
    More low-hanging fruit: antibiotic chelation drug interactions
    Rachel M Kenney, PharmD; Charles T Makowski, PharmD; Brian Church, PharmD; Susan L Davis, PharmD
    Duration of Antimicrobial Therapy: The Impact of Defaults
    Rebekah Wrenn, PharmD; Tony Diez, Sr., MBA, RRT; Nicholas Turner, MD; Christina Sarubbi, PharmD; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Rebekah W. Moehring, MD, MPH
  • Wrenn Duration IDWeek 2018 .pdf (573.4 kB)
  • 194
    Mandatory Antimicrobial Duration at the Time of Computerized Physician Order Entry: What’s the Harm?
    Alaina Burns, PharmD; Ann Wirtz, PharmD; Gina Weddle, DNP, RN, CPNP; Tammy Frank, RPh, CPHIMS; Richard Ogden, PharmD, MBA, BCPS; Brian O'Neal, PharmD, MS, FASHP; Jennifer Goldman, MD, MS

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.